...
首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >In vivo evaluation of isolated triterpenes and semi-synthetic derivatives as antimalarial agents
【24h】

In vivo evaluation of isolated triterpenes and semi-synthetic derivatives as antimalarial agents

机译:体内评估的分离的三萜和半合成衍生物作为抗疟药

获取原文
获取原文并翻译 | 示例

摘要

The triterpenes balsaminoside B (1) and karavilagenin C (2) were isolated from the African medicinal plant Momordica balsamina L. Karavoates B (3) and D (4) were synthesized by diacylation of 2 with acetic and propionic anhydrides, respectively. In previous work, derivatives 3 and 4 exhibited submicromolar median inhibitory concentrations (IC50) in vitro against Plasmodium falciparum Welch (human malaria parasite) strains 20 to 25 times lower than those of natural product 2. The main objective of the present study was to explore structure-in vivo antimalarial activity relationships (SAR) for compounds 1-4 in Plasmodium berghei Vincke and Lips NK65-infected mice in the 4 day suppressive test. Semi-synthetic derivatives 3 and 4 exhibited greater in vivo antimalarial activity than isolates 1 and 2. Orally and subcutaneously administered karavoate B exhibited the greatest in vivo antimalarial activity (55.2-58.1% maximal suppression of parasitemia at doses of 50 mg kg(-1) day(-1)). Diacylation of natural isolate 2 with short chain carboxylic acid moieties yielded derivatives with enhanced maximal in vivo parasitemia suppression for both routes of administration. Maximal in vivo parasite suppression by diacetyl derivative 3 was roughly double that of natural precursor 2. (C) 2015 Published by Elsevier Masson SAS.
机译:从非洲药用植物苦瓜(Morordica balsamina L)中分离出三萜类香脂甙B(1)和karavilagenin C(2)。分别通过2与乙酸酐和丙酸酐的二酰化反应合成Karavoates B(3)和D(4)。在先前的工作中,衍生物3和4在体外对恶性疟原虫Welch(人类疟疾寄生虫)菌株的亚微摩尔抑制浓度(IC50)比天然产物2低20至25倍。本研究的主要目的是探索在第4天抑制测试中,伯氏疟原虫Vincke和Lips NK6​​5感染的小鼠体内化合物1-4的体内结构抗疟活性关系(SAR)。半合成衍生物3和4表现出比分离物1和2更高的体内抗疟疾活性。口服和皮下施用卡拉沃酸酯B表现出最大的体内抗疟疾活性(55.2-58.1%在剂量为50 mg kg(-1时最大程度地抑制寄生虫病) )天(-1))。天然分离物2与短链羧酸部分的二酰基化产生了两种给药途径均具有最大体内寄生虫抑制作用增强的衍生物。二乙酰基衍生物3对体内寄生虫的最大抑制作用约为天然前体2的两倍。(C)2015由Elsevier Masson SAS发布。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号